Global Competent Cells Market Size, Status and Forecast 2022

Publisher Name :
Date: 10-Jan-2022
No. of pages: 128
Inquire Before Buying

Competent Cells market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Competent Cells market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Chemically Competent Cells

- Electrocompetent Cells

Segment by Application

- Subcloning & Routine Cloning

- Phage Display Library Construction

- Toxic/Unstable DNA Cloning

- High-Throughput Cloning

- Protein Expression

- Mutagenesis

- Single-Stranded DNA Production

- Bacmid Creation

- Cre-Lox Recombination (PIR1/PIR2)

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Merck KGaA

- Thermo Fisher Scientific

- Agilent Technologies

- Takara Bio

- Promega Corporation

- Beijing TransGen Biotech

- GeneScript Corporation

- Yeastern Biotech

- New England Biolabs

- QIAGEN N.V.

- OriGene Technologies

- Lucigen

- Zymo Research

- Bio-Rad Laboratories

- Bioline

- Delphi Genetics

- IBA GmBH

- Cell Applications

- BioDynamics Laboratory

- Scarab Genomics

- GCC Biotech

- SMOBIO Technology

- Edge BioSystems

Global Competent Cells Market Size, Status and Forecast 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Competent Cells Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemically Competent Cells
1.2.3 Electrocompetent Cells
1.3 Market by Application
1.3.1 Global Competent Cells Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Subcloning & Routine Cloning
1.3.3 Phage Display Library Construction
1.3.4 Toxic/Unstable DNA Cloning
1.3.5 High-Throughput Cloning
1.3.6 Protein Expression
1.3.7 Mutagenesis
1.3.8 Single-Stranded DNA Production
1.3.9 Bacmid Creation
1.3.10 Cre-Lox Recombination (PIR1/PIR2)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Competent Cells Market Perspective (2016-2027)
2.2 Competent Cells Growth Trends by Regions
2.2.1 Competent Cells Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Competent Cells Historic Market Share by Regions (2016-2021)
2.2.3 Competent Cells Forecasted Market Size by Regions (2022-2027)
2.3 Competent Cells Industry Dynamic
2.3.1 Competent Cells Market Trends
2.3.2 Competent Cells Market Drivers
2.3.3 Competent Cells Market Challenges
2.3.4 Competent Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Competent Cells Players by Revenue
3.1.1 Global Top Competent Cells Players by Revenue (2016-2021)
3.1.2 Global Competent Cells Revenue Market Share by Players (2016-2021)
3.2 Global Competent Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Competent Cells Revenue
3.4 Global Competent Cells Market Concentration Ratio
3.4.1 Global Competent Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Competent Cells Revenue in 2020
3.5 Competent Cells Key Players Head office and Area Served
3.6 Key Players Competent Cells Product Solution and Service
3.7 Date of Enter into Competent Cells Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Competent Cells Breakdown Data by Type
4.1 Global Competent Cells Historic Market Size by Type (2016-2021)
4.2 Global Competent Cells Forecasted Market Size by Type (2022-2027)
5 Competent Cells Breakdown Data by Application
5.1 Global Competent Cells Historic Market Size by Application (2016-2021)
5.2 Global Competent Cells Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Competent Cells Market Size (2016-2027)
6.2 North America Competent Cells Market Size by Type
6.2.1 North America Competent Cells Market Size by Type (2016-2021)
6.2.2 North America Competent Cells Market Size by Type (2022-2027)
6.2.3 North America Competent Cells Market Size by Type (2016-2027)
6.3 North America Competent Cells Market Size by Application
6.3.1 North America Competent Cells Market Size by Application (2016-2021)
6.3.2 North America Competent Cells Market Size by Application (2022-2027)
6.3.3 North America Competent Cells Market Size by Application (2016-2027)
6.4 North America Competent Cells Market Size by Country
6.4.1 North America Competent Cells Market Size by Country (2016-2021)
6.4.2 North America Competent Cells Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Competent Cells Market Size (2016-2027)
7.2 Europe Competent Cells Market Size by Type
7.2.1 Europe Competent Cells Market Size by Type (2016-2021)
7.2.2 Europe Competent Cells Market Size by Type (2022-2027)
7.2.3 Europe Competent Cells Market Size by Type (2016-2027)
7.3 Europe Competent Cells Market Size by Application
7.3.1 Europe Competent Cells Market Size by Application (2016-2021)
7.3.2 Europe Competent Cells Market Size by Application (2022-2027)
7.3.3 Europe Competent Cells Market Size by Application (2016-2027)
7.4 Europe Competent Cells Market Size by Country
7.4.1 Europe Competent Cells Market Size by Country (2016-2021)
7.4.2 Europe Competent Cells Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Competent Cells Market Size (2016-2027)
8.2 Asia-Pacific Competent Cells Market Size by Type
8.2.1 Asia-Pacific Competent Cells Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Competent Cells Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Competent Cells Market Size by Type (2016-2027)
8.3 Asia-Pacific Competent Cells Market Size by Application
8.3.1 Asia-Pacific Competent Cells Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Competent Cells Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Competent Cells Market Size by Application (2016-2027)
8.4 Asia-Pacific Competent Cells Market Size by Region
8.4.1 Asia-Pacific Competent Cells Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Competent Cells Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Competent Cells Market Size (2016-2027)
9.2 Latin America Competent Cells Market Size by Type
9.2.1 Latin America Competent Cells Market Size by Type (2016-2021)
9.2.2 Latin America Competent Cells Market Size by Type (2022-2027)
9.2.3 Latin America Competent Cells Market Size by Type (2016-2027)
9.3 Latin America Competent Cells Market Size by Application
9.3.1 Latin America Competent Cells Market Size by Application (2016-2021)
9.3.2 Latin America Competent Cells Market Size by Application (2022-2027)
9.3.3 Latin America Competent Cells Market Size by Application (2016-2027)
9.4 Latin America Competent Cells Market Size by Country
9.4.1 Latin America Competent Cells Market Size by Country (2016-2021)
9.4.2 Latin America Competent Cells Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Competent Cells Market Size (2016-2027)
10.2 Middle East & Africa Competent Cells Market Size by Type
10.2.1 Middle East & Africa Competent Cells Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Competent Cells Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Competent Cells Market Size by Type (2016-2027)
10.3 Middle East & Africa Competent Cells Market Size by Application
10.3.1 Middle East & Africa Competent Cells Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Competent Cells Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Competent Cells Market Size by Application (2016-2027)
10.4 Middle East & Africa Competent Cells Market Size by Country
10.4.1 Middle East & Africa Competent Cells Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Competent Cells Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Competent Cells Introduction
11.1.4 Merck KGaA Revenue in Competent Cells Business (2016-2021)
11.1.5 Merck KGaA Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Competent Cells Introduction
11.2.4 Thermo Fisher Scientific Revenue in Competent Cells Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Competent Cells Introduction
11.3.4 Agilent Technologies Revenue in Competent Cells Business (2016-2021)
11.3.5 Agilent Technologies Recent Development
11.4 Takara Bio
11.4.1 Takara Bio Company Details
11.4.2 Takara Bio Business Overview
11.4.3 Takara Bio Competent Cells Introduction
11.4.4 Takara Bio Revenue in Competent Cells Business (2016-2021)
11.4.5 Takara Bio Recent Development
11.5 Promega Corporation
11.5.1 Promega Corporation Company Details
11.5.2 Promega Corporation Business Overview
11.5.3 Promega Corporation Competent Cells Introduction
11.5.4 Promega Corporation Revenue in Competent Cells Business (2016-2021)
11.5.5 Promega Corporation Recent Development
11.6 Beijing TransGen Biotech
11.6.1 Beijing TransGen Biotech Company Details
11.6.2 Beijing TransGen Biotech Business Overview
11.6.3 Beijing TransGen Biotech Competent Cells Introduction
11.6.4 Beijing TransGen Biotech Revenue in Competent Cells Business (2016-2021)
11.6.5 Beijing TransGen Biotech Recent Development
11.7 GeneScript Corporation
11.7.1 GeneScript Corporation Company Details
11.7.2 GeneScript Corporation Business Overview
11.7.3 GeneScript Corporation Competent Cells Introduction
11.7.4 GeneScript Corporation Revenue in Competent Cells Business (2016-2021)
11.7.5 GeneScript Corporation Recent Development
11.8 Yeastern Biotech
11.8.1 Yeastern Biotech Company Details
11.8.2 Yeastern Biotech Business Overview
11.8.3 Yeastern Biotech Competent Cells Introduction
11.8.4 Yeastern Biotech Revenue in Competent Cells Business (2016-2021)
11.8.5 Yeastern Biotech Recent Development
11.9 New England Biolabs
11.9.1 New England Biolabs Company Details
11.9.2 New England Biolabs Business Overview
11.9.3 New England Biolabs Competent Cells Introduction
11.9.4 New England Biolabs Revenue in Competent Cells Business (2016-2021)
11.9.5 New England Biolabs Recent Development
11.10 QIAGEN N.V.
11.10.1 QIAGEN N.V. Company Details
11.10.2 QIAGEN N.V. Business Overview
11.10.3 QIAGEN N.V. Competent Cells Introduction
11.10.4 QIAGEN N.V. Revenue in Competent Cells Business (2016-2021)
11.10.5 QIAGEN N.V. Recent Development
11.11 OriGene Technologies
11.11.1 OriGene Technologies Company Details
11.11.2 OriGene Technologies Business Overview
11.11.3 OriGene Technologies Competent Cells Introduction
11.11.4 OriGene Technologies Revenue in Competent Cells Business (2016-2021)
11.11.5 OriGene Technologies Recent Development
11.12 Lucigen
11.12.1 Lucigen Company Details
11.12.2 Lucigen Business Overview
11.12.3 Lucigen Competent Cells Introduction
11.12.4 Lucigen Revenue in Competent Cells Business (2016-2021)
11.12.5 Lucigen Recent Development
11.13 Zymo Research
11.13.1 Zymo Research Company Details
11.13.2 Zymo Research Business Overview
11.13.3 Zymo Research Competent Cells Introduction
11.13.4 Zymo Research Revenue in Competent Cells Business (2016-2021)
11.13.5 Zymo Research Recent Development
11.14 Bio-Rad Laboratories
11.14.1 Bio-Rad Laboratories Company Details
11.14.2 Bio-Rad Laboratories Business Overview
11.14.3 Bio-Rad Laboratories Competent Cells Introduction
11.14.4 Bio-Rad Laboratories Revenue in Competent Cells Business (2016-2021)
11.14.5 Bio-Rad Laboratories Recent Development
11.15 Bioline
11.15.1 Bioline Company Details
11.15.2 Bioline Business Overview
11.15.3 Bioline Competent Cells Introduction
11.15.4 Bioline Revenue in Competent Cells Business (2016-2021)
11.15.5 Bioline Recent Development
11.16 Delphi Genetics
11.16.1 Delphi Genetics Company Details
11.16.2 Delphi Genetics Business Overview
11.16.3 Delphi Genetics Competent Cells Introduction
11.16.4 Delphi Genetics Revenue in Competent Cells Business (2016-2021)
11.16.5 Delphi Genetics Recent Development
11.17 IBA GmBH
11.17.1 IBA GmBH Company Details
11.17.2 IBA GmBH Business Overview
11.17.3 IBA GmBH Competent Cells Introduction
11.17.4 IBA GmBH Revenue in Competent Cells Business (2016-2021)
11.17.5 IBA GmBH Recent Development
11.18 Cell Applications
11.18.1 Cell Applications Company Details
11.18.2 Cell Applications Business Overview
11.18.3 Cell Applications Competent Cells Introduction
11.18.4 Cell Applications Revenue in Competent Cells Business (2016-2021)
11.18.5 Cell Applications Recent Development
11.19 BioDynamics Laboratory
11.19.1 BioDynamics Laboratory Company Details
11.19.2 BioDynamics Laboratory Business Overview
11.19.3 BioDynamics Laboratory Competent Cells Introduction
11.19.4 BioDynamics Laboratory Revenue in Competent Cells Business (2016-2021)
11.19.5 BioDynamics Laboratory Recent Development
11.20 Scarab Genomics
11.20.1 Scarab Genomics Company Details
11.20.2 Scarab Genomics Business Overview
11.20.3 Scarab Genomics Competent Cells Introduction
11.20.4 Scarab Genomics Revenue in Competent Cells Business (2016-2021)
11.20.5 Scarab Genomics Recent Development
11.21 GCC Biotech
11.21.1 GCC Biotech Company Details
11.21.2 GCC Biotech Business Overview
11.21.3 GCC Biotech Competent Cells Introduction
11.21.4 GCC Biotech Revenue in Competent Cells Business (2016-2021)
11.21.5 GCC Biotech Recent Development
11.22 SMOBIO Technology
11.22.1 SMOBIO Technology Company Details
11.22.2 SMOBIO Technology Business Overview
11.22.3 SMOBIO Technology Competent Cells Introduction
11.22.4 SMOBIO Technology Revenue in Competent Cells Business (2016-2021)
11.22.5 SMOBIO Technology Recent Development
11.23 Edge BioSystems
11.23.1 Edge BioSystems Company Details
11.23.2 Edge BioSystems Business Overview
11.23.3 Edge BioSystems Competent Cells Introduction
11.23.4 Edge BioSystems Revenue in Competent Cells Business (2016-2021)
11.23.5 Edge BioSystems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Competent Cells Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemically Competent Cells
Table 3. Key Players of Electrocompetent Cells
Table 4. Global Competent Cells Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Competent Cells Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Competent Cells Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Competent Cells Market Share by Regions (2016-2021)
Table 8. Global Competent Cells Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Competent Cells Market Share by Regions (2022-2027)
Table 10. Competent Cells Market Trends
Table 11. Competent Cells Market Drivers
Table 12. Competent Cells Market Challenges
Table 13. Competent Cells Market Restraints
Table 14. Global Competent Cells Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Competent Cells Market Share by Players (2016-2021)
Table 16. Global Top Competent Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Competent Cells as of 2020)
Table 17. Ranking of Global Top Competent Cells Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Competent Cells Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Competent Cells Product Solution and Service
Table 21. Date of Enter into Competent Cells Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Competent Cells Revenue Market Share by Type (2016-2021)
Table 25. Global Competent Cells Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Competent Cells Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Competent Cells Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Competent Cells Revenue Market Share by Application (2016-2021)
Table 29. Global Competent Cells Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Competent Cells Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Competent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Competent Cells Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Competent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Competent Cells Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Competent Cells Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Competent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Competent Cells Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Competent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Competent Cells Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Competent Cells Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Competent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Competent Cells Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Competent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Competent Cells Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Competent Cells Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Competent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Competent Cells Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Competent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Competent Cells Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Competent Cells Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Competent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Competent Cells Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Competent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Competent Cells Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Competent Cells Market Size by Country (2022-2027) & (US$ Million)
Table 61. Merck KGaA Company Details
Table 62. Merck KGaA Business Overview
Table 63. Merck KGaA Competent Cells Product
Table 64. Merck KGaA Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 65. Merck KGaA Recent Development
Table 66. Thermo Fisher Scientific Company Details
Table 67. Thermo Fisher Scientific Business Overview
Table 68. Thermo Fisher Scientific Competent Cells Product
Table 69. Thermo Fisher Scientific Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 70. Thermo Fisher Scientific Recent Development
Table 71. Agilent Technologies Company Details
Table 72. Agilent Technologies Business Overview
Table 73. Agilent Technologies Competent Cells Product
Table 74. Agilent Technologies Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 75. Agilent Technologies Recent Development
Table 76. Takara Bio Company Details
Table 77. Takara Bio Business Overview
Table 78. Takara Bio Competent Cells Product
Table 79. Takara Bio Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 80. Takara Bio Recent Development
Table 81. Promega Corporation Company Details
Table 82. Promega Corporation Business Overview
Table 83. Promega Corporation Competent Cells Product
Table 84. Promega Corporation Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 85. Promega Corporation Recent Development
Table 86. Beijing TransGen Biotech Company Details
Table 87. Beijing TransGen Biotech Business Overview
Table 88. Beijing TransGen Biotech Competent Cells Product
Table 89. Beijing TransGen Biotech Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 90. Beijing TransGen Biotech Recent Development
Table 91. GeneScript Corporation Company Details
Table 92. GeneScript Corporation Business Overview
Table 93. GeneScript Corporation Competent Cells Product
Table 94. GeneScript Corporation Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 95. GeneScript Corporation Recent Development
Table 96. Yeastern Biotech Company Details
Table 97. Yeastern Biotech Business Overview
Table 98. Yeastern Biotech Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 99. Yeastern Biotech Recent Development
Table 100. New England Biolabs Company Details
Table 101. New England Biolabs Business Overview
Table 102. New England Biolabs Competent Cells Product
Table 103. New England Biolabs Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 104. New England Biolabs Recent Development
Table 105. QIAGEN N.V. Company Details
Table 106. QIAGEN N.V. Business Overview
Table 107. QIAGEN N.V. Competent Cells Product
Table 108. QIAGEN N.V. Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 109. QIAGEN N.V. Recent Development
Table 110. OriGene Technologies Company Details
Table 111. OriGene Technologies Business Overview
Table 112. OriGene Technologies Competent Cells Product
Table 113. OriGene Technologies Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 114. OriGene Technologies Recent Development
Table 115. Lucigen Company Details
Table 116. Lucigen Business Overview
Table 117. Lucigen Competent Cells Product
Table 118. Lucigen Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 119. Lucigen Recent Development
Table 120. Zymo Research Company Details
Table 121. Zymo Research Business Overview
Table 122. Zymo Research Competent Cells Product
Table 123. Zymo Research Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 124. Zymo Research Recent Development
Table 125. Bio-Rad Laboratories Company Details
Table 126. Bio-Rad Laboratories Business Overview
Table 127. Bio-Rad Laboratories Competent Cells Product
Table 128. Bio-Rad Laboratories Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 129. Bio-Rad Laboratories Recent Development
Table 130. Bioline Company Details
Table 131. Bioline Business Overview
Table 132. Bioline Competent Cells Product
Table 133. Bioline Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 134. Bioline Recent Development
Table 135. Delphi Genetics Company Details
Table 136. Delphi Genetics Business Overview
Table 137. Delphi Genetics Competent Cells Product
Table 138. Delphi Genetics Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 139. Delphi Genetics Recent Development
Table 140. IBA GmBH Company Details
Table 141. IBA GmBH Business Overview
Table 142. IBA GmBH Competent Cells Product
Table 143. IBA GmBH Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 144. IBA GmBH Recent Development
Table 145. Cell Applications Company Details
Table 146. Cell Applications Business Overview
Table 147. Cell Applications Competent Cells Product
Table 148. Cell Applications Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 149. Cell Applications Recent Development
Table 150. BioDynamics Laboratory Company Details
Table 151. BioDynamics Laboratory Business Overview
Table 152. BioDynamics Laboratory Competent Cells Product
Table 153. BioDynamics Laboratory Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 154. BioDynamics Laboratory Recent Development
Table 155. Scarab Genomics Company Details
Table 156. Scarab Genomics Business Overview
Table 157. Scarab Genomics Competent Cells Product
Table 158. Scarab Genomics Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 159. Scarab Genomics Recent Development
Table 160. GCC Biotech Company Details
Table 161. GCC Biotech Business Overview
Table 162. GCC Biotech Competent Cells Product
Table 163. GCC Biotech Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 164. GCC Biotech Recent Development
Table 165. SMOBIO Technology Company Details
Table 166. SMOBIO Technology Business Overview
Table 167. SMOBIO Technology Competent Cells Product
Table 168. SMOBIO Technology Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 169. SMOBIO Technology Recent Development
Table 170. Edge BioSystems Company Details
Table 171. Edge BioSystems Business Overview
Table 172. Edge BioSystems Competent Cells Product
Table 173. Edge BioSystems Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 174. Edge BioSystems Recent Development
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Competent Cells Market Share by Type: 2020 VS 2027
Figure 2. Chemically Competent Cells Features
Figure 3. Electrocompetent Cells Features
Figure 4. Global Competent Cells Market Share by Application: 2020 VS 2027
Figure 5. Subcloning & Routine Cloning Case Studies
Figure 6. Phage Display Library Construction Case Studies
Figure 7. Toxic/Unstable DNA Cloning Case Studies
Figure 8. High-Throughput Cloning Case Studies
Figure 9. Protein Expression Case Studies
Figure 10. Mutagenesis Case Studies
Figure 11. Single-Stranded DNA Production Case Studies
Figure 12. Bacmid Creation Case Studies
Figure 13. Cre-Lox Recombination (PIR1/PIR2) Case Studies
Figure 14. Competent Cells Report Years Considered
Figure 15. Global Competent Cells Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Competent Cells Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Competent Cells Market Share by Regions: 2020 VS 2027
Figure 18. Global Competent Cells Market Share by Regions (2022-2027)
Figure 19. Global Competent Cells Market Share by Players in 2020
Figure 20. Global Top Competent Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Competent Cells as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Competent Cells Revenue in 2020
Figure 22. Global Competent Cells Revenue Market Share by Type (2016-2021)
Figure 23. Global Competent Cells Revenue Market Share by Type (2022-2027)
Figure 24. North America Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Competent Cells Market Share by Type (2016-2027)
Figure 26. North America Competent Cells Market Share by Application (2016-2027)
Figure 27. North America Competent Cells Market Share by Country (2016-2027)
Figure 28. United States Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Competent Cells Market Share by Type (2016-2027)
Figure 32. Europe Competent Cells Market Share by Application (2016-2027)
Figure 33. Europe Competent Cells Market Share by Country (2016-2027)
Figure 34. Germany Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Competent Cells Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Competent Cells Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Competent Cells Market Share by Region (2016-2027)
Figure 44. China Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Competent Cells Market Share by Type (2016-2027)
Figure 52. Latin America Competent Cells Market Share by Application (2016-2027)
Figure 53. Latin America Competent Cells Market Share by Country (2016-2027)
Figure 54. Mexico Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Competent Cells Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Competent Cells Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Competent Cells Market Share by Country (2016-2027)
Figure 60. Turkey Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Competent Cells Market Size YoY Growt
  • Global Cytokine Inhibitor Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Cytokine Inhibitor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The development prospects of cytokine inhibitors are very broad, and these drugs have many medical applications and researches. Cytokine inhibitors can reduce The activity of cytokines, thereby inhibiting their role in immune responses and reducing The activation of immune cells and The occurrence o......
  • Global Microbial Growth Media Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    Microbial Growth Media is a nutrient component required by microorganisms, containing a variety of trace elements and trace elements, such as copper, iron, zinc, cobalt, manganese, etc. The global Microbial Growth Media market was valued at US$ 8007 million in 2023 and is anticipated to reach US$ 11530 million by 2030, witnessing a CAGR of 5.3% during The forecast period 2024-2030. The market for microbial growth media is essential in microbiology and biotechnology rese......
  • Global Protein Biochip Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 92
    Protein Biochip is a small Protein array used to quickly detect a large number of unknown proteins. It works in a similar way to a DNA chip. First, a large number of known proteins (such as monoclonal antibodies) are placed on a small substrate and then exposed to and reacted with The unknown protein sample. Due to The specific binding between The antigen and The antibody, it can finally be detected by means of laser. The global Protein Biochip market was valued at US$ 145 million i......
  • Global Isothermal Nucleic Acid Amplification Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 103
    Isothermal nucleic acid amplification is referred to isothermal nucleic acid amplification technology. And in this report, we get The statistics on reagents used in isothermal nucleic acid amplification technology. Nucleic acid isothermal amplification is a newer technique that amplifies DNA or RNA specific fragment from few copies to billion-fold copies under a one temperature condition, unlike PCR amplification that needs at least 30-35 thermal cycles to accomplish The reaction. T......
  • Global Microfluidics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Microfluidics market size was valued at US$ 3118.7 million in 2023. With growing demand in downstream market, the Microfluidics is forecast to a readjusted size of US$ 7707.1 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Microfluidics market. Microfluidics are expected to show stable growth in the future market. However, product differentiation, re......
  • Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 122
    According to our LPI (LP Information) latest study, the global Isothermal Nucleic Acid Amplification Technology (INAAT) market size was valued at US$ 6141.3 million in 2023. With growing demand in downstream market, the Isothermal Nucleic Acid Amplification Technology (INAAT) is forecast to a readjusted size of US$ 11250 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Isothermal Nucleic Acid Amplification Technol......
  • Global Cytokines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119
    According to our LPI (LP Information) latest study, the global Cytokines market size was valued at US$ 203730 million in 2023. With growing demand in downstream market, the Cytokines is forecast to a readjusted size of US$ 611910 million by 2030 with a CAGR of 17.0% during review period. The research report highlights the growth potential of the global Cytokines market. Cytokines are expected to show stable growth in the future market. However, product differentiation, reducing costs, an......
  • Global Western Blot Imagers Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Western Blot Imagers market size was valued at US$ 406 million in 2023. With growing demand in downstream market, the Western Blot Imagers is forecast to a readjusted size of US$ 578.4 million by 2030 with a CAGR of 5.2% during review period. The research report highlights the growth potential of the global Western Blot Imagers market. Western Blot Imagers are expected to show stable growth in the future market. However, prod......
  • Global Procalcitonin Antibody Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125
    According to our LPI (LP Information) latest study, the global Procalcitonin Antibody market size was valued at US$ million in 2023. With growing demand in downstream market, the Procalcitonin Antibody is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Procalcitonin Antibody market. Procalcitonin Antibody are expected to show stable growth in the future market. However, product di......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs